Multiple myeloma trials in France

In France 92 Also abroad 703

92 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
CAR-T Immunomonitoring in Multiple Myeloma (CART I5M)
Where
Poitiers
Age
18 years and over
People
60
Run by
Poitiers University Hospital
See details and how to joinNCT07342179
Phase 2Not yet taking people in France
A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Where
Paris
Age
18 years and over
People
70
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07348393
No phaseNot yet taking people in France
Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma
Where
Paris
Age
18 years and over
People
27
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07276230
No phaseTaking people
ICOPE Program Feasibility in the Management of Myeloma Patients
Where
Toulouse
Age
70 years and over
People
30
Run by
University Hospital, Toulouse
See details and how to joinNCT06247189
No phaseTaking people
Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
Where
Amiens
Age
18 years and over
People
25
Run by
Centre Hospitalier Universitaire, Amiens
See details and how to joinNCT07180992
No phaseTaking people
Impact of an Early Warning System on the Prognosis of Patients With Hematological Malignancies Receiving Intensive Chemotherapy With or Without Hematopoietic Cell Transplantation.
Where
Amiens, Angers, Besançon, Brest, Nancy, Nantes, Poitiers, Saint-Etienne, Strasbourg, Tours
Age
18 years and over
People
2,224
Run by
University Hospital, Angers
See details and how to joinNCT06409767
No phaseTaking people
Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients
Where
Paris
Age
18 years and over
People
30
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06133426
No phaseTaking people
Early Assessment of Cardiac Function After Treatment With CAR-T Cells
Where
Paris
Age
18 years and over
People
60
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06350994
No phaseTaking people
MYeloma Resistance And Clonal Evolution
Where
La Roche-sur-Yon, Nantes
Age
18 years and over
People
1,400
Run by
Nantes University Hospital
See details and how to joinNCT03807128
Phase 2Not yet taking people in France
Comparison of Elranatamab and Lenalidomide Versus Daratumumab and Lenalidomide as Post-transplant Maintenance Therapy in Patients With Newly Diagnosed Myeloma (ElMMA)
Where
Angers, Bayonne, Besançon, Caen, Clamart, Clermont-Ferrand, Créteil, Dijon, Épagny, La Roche-sur-Yon, Le Mans, Libourne, Limoges, Lorient, Lyon, Marseille, Nancy, Nantes, Nice, Nîmes, Paris, Périgueux, Perpignan, Pessac, Poitiers, Quimper, Saint-Nazaire, Strasbourg, Tarbes, Toulouse, Tours, Vannes
Age
18 years and over
People
176
Run by
Nantes University Hospital
See details and how to joinNCT06931704
No phaseTaking people
Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination
Where
Amiens, Caen, Dijon, Epagny Metz- Tessy, Lille, Lyon, Montpellier, Paris, Pessac, Pierre-Bénite, Poitiers, Rennes, Saint-Priest-en-Jarez, Toulouse, Tours, Vandœuvre-lès-Nancy
Age
18 years and over
People
100
Run by
University Hospital, Toulouse
See details and how to joinNCT05945524
No phaseTaking people
Cost-utility Analysis of Ambulatory Dose Escalation of Bispecific Antibodies in Multiple Myeloma.
Where
Toulouse
Age
18 years and over
People
40
Run by
University Hospital, Toulouse
See details and how to joinNCT06846905
Phase 3Taking people
Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone
Where
Abbeville, Aix En Provence, Argenteuil, Avignon, Blois Cedex, Bobigny Cedex, Bordeaux, Caen Cedex 9, Castelnauv Le Lez, Cesson Sevigne, Chalon Sur Saone Cedex, Chambéry, Clamart, Clermont-Ferrand, Compiegne, Creteil Cedex, Dijon, Dunkirk Cedex 1, La Rochelle, La Roche Sur Yon Cedex 9, La Tronche, Le Chesnay Rocquencourt, Le Coudray, Lens, Lille, Lille Cedex, Lorient, Metz Cedex 03, Montivilliers, Montpellier Cedex 5, Nantes, Nantes Cedex 2, Niort, Paris, Paris Cedex 12, Périgueux, Pringy Cedex, Reims Cedex, Rouen, Saint-Priest-en-Jarez, Saint-Quentin, Tours, Troyes Cedex, Vandoeuvre Les Nancy Cedex, Vannes
Age
18 years and over
People
318
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06561854 · EU 2024-510981-18-00
No phaseTaking people
Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment.
Where
Paris
Age
18 years and over
People
260
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05203003
Phase 2Taking people
FCH vs FDG PET/CT in Detection of Lesions in Patients With Multiple Myeloma (MIM)
Where
Besancon Cedex, Dijon
Age
18 years to 75 years
People
38
Run by
Centre Georges Francois Leclerc
See details and how to joinNCT04349358 · EU 2024-516682-36-00
No phaseNot yet taking people in France
Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies
Where
Paris
Age
18 years and over
People
30
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT04702932
No phaseTaking people
Institut Paoli Calmettes Multiple Myeloma Database
Where
Marseille
Age
18 years to 95 years
People
5,000
Run by
Institut Paoli-Calmettes
See details and how to joinNCT02869555